An official website of the United States government.

This is not the current EPA website. To navigate to the current EPA website, please go to www.epa.gov. This website is historical material reflecting the EPA website as it existed on January 19, 2021. This website is no longer updated and links to external websites and some internal pages may not work. More information »

Pesticides

EPA Accepting Public Comments on Candidates Under Consideration for Ad Hoc Participation on the FIFRA SAP

For Release: July 16, 2020

EPA is now accepting public comments on the experts under consideration for ad hoc participation in the Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel’s (FIFRA SAP’s) review of the use of NAMs to derive extrapolation factors, which will take place September 15-18, 2020, (www.regulations.gov, docket no. EPA-HQ-OPP-2020-0263).

Biographies of these candidates are available on the FIFRA SAP website at https://19january2021snapshot.epa.gov/sap. Public comments – which must be submitted on or before July 31, 2020 – will be used to assist the Agency in selecting ad hoc participants for the upcoming review. Comments may be submitted to docket ID number EPA-HQ-OPP-2020-0263. For additional information, please see the Federal Register notice for this meeting  or contact Steven M. Knott ( knott.steven@epa.gov), M.S., Designated Federal Officer, Office of Science Coordination and Policy, Environmental Protection Agency (202-564-0103).

The FIFRA SAP serves as a primary scientific peer review mechanism of EPA’s Office of Chemical Safety and Pollution Prevention (OCSPP) and is structured to provide scientific advice, information and recommendations to the EPA Administrator on pesticides and pesticide-related issues as to the impact of regulatory actions on health and the environment. During the meeting on September 15-18, 2020, the FIFRA SAP will consider and review EPA activities that could inform human health risk assessment for organophosphate pesticides and reducing animal testing. EPA is considering using in vitro data for 16 organophosphate compounds to potentially reduce reliance on default risk assessment uncertainty factors in favor of more refined data-derived factors.